ME241220C00003000

OPR - OPR Delayed Price. Currency in USD

0.4000

-0.0500

(-11.11%)

As of 11:23AM EST. Market open.

MedTech Dive
23andMe to lay off more than 200 employees amid business struggles
The genetic testing firm will also close its therapeutics arm. CEO Anne Wojcicki said the cuts are necessary to “focus on the long-term success of our core consumer business.”
GuruFocus.com
23andMe Holding Co (ME) Q2 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
Despite a revenue decline, 23andMe Holding Co (ME) focuses on cost-saving measures and recurring revenue growth to enhance financial stability.